Abstract
In this review the current knowledge of protein degradation during preparation, storage and release from poly(lactic-co-glycolic acid) (PLGA) microparticles is described, as well as stabilization approaches. Although we have focussed on PLGA microparticles, the degradation processes and mechanisms described here are valid for many other polymeric release systems. Optimized process conditions as well as stabilizing excipients need to be used to counteract several stress factors that compromise the integrity of protein structure during preparation, storage, and release. The use of various stabilization approaches has rendered some success in increasing protein stability, but, still, full preservation of the native protein structure remains a major challenge in the formulation of protein-loaded PLGA microparticles.
Similar content being viewed by others
REFERENCES
G. Crotts and T. G. Park. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J. Microencapsul. 15:699–713 (1998).
W. R. Gombotz and D. K. Pettit. Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem. 6:332–351 (1995).
K. L. Smith, M. E. Schimpf, and K. E. Thompson. Bioerodible polymers for delivery of macromolecules. Adv. Drug Del. Rev. 4:343–357 (1990).
J. L. Cleland and A. J. S. Jones. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 13:1464–1475 (1996).
J. L. Cleland, E. Duenas, A. Daugherty, M. Marian, J. Yang, M. Wilson, A. C. Celniker, A. Shahzamani, V. Quarmby, H. Chu, V. Mukku, A. Mac, M. Roussakis, N. Gillette, B. Boyd, D. Yeung, D. Brooks, Y.-F. Maa, C. Hsu, and A. J. S. Jones. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Release 49: 193–205 (1997).
J. L. Cleland. Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Biotechnol. Prog. 14:102–107 (1998).
O. L. Johnson, W. Jaworowicz, J. L. Cleland, L. Bailey, M. Charnis, E. Duenas, C. Wu, D. Shepard, S. Magil, T. Last, A. J. S. Jones, and S. D. Putney. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14:730–735 (1997).
H. K. Kim and T. G. Park. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation, stability and incomplete release mechanism. Biotechnol. Bioeng. 65:659–667 (1999).
M. A. Tracy. Development and scale-up of a microsphere protein delivery system. Biotechnol. Prog. 14:108–115 (1998).
T.-H. Yang, A. Dong, J. Meyer, O. L. Johnson, J. L. Cleland, and J. F. Carpenter. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. J. Pharm. Sci. 88:161–165 (1999).
L. Chen, R. N. Apte, and S. Cohen. Characterization of PLGA microspheres for the controlled delivery of IL1α for tumor immunotherapy. J. Control. Release 43:261–272 (1997).
D. K. Pettit, J. R. Lawter, W. J. Huang, S. C. Pankey, N. S. Nightlinger, D. H. Lynch, J. A. C. L. Schuh, P. J. Morrissey, and W. R. Gombotz. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF. Pharm. Res. 14:1422–1430 (1997).
J. Yang and J. L. Cleland. Factors affecting the in vitro release of recombinant human interferon-γ (rhIFN-γ) from PLGA microspheres. J. Pharm. Sci. 86:908–914 (1997).
M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 12:299–306 (1994).
D. K.-L. Xing, D. T. Crane, B. Bolgiano, M. J. Corbel, C. Jones, and D. Sesardic. Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. Vaccine 14:1205–1213 (1996).
P. Johansen, H. P. Merkle, and B. Gander. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability. Biochim. Biophys. Acta 1425:425–436 (1998).
P. Johansen, Y. Men, R. Audran, G. Corradin, H. P. Merkle, and B. Gander. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm. Res. 15:1103–1110 (1998).
P. Johansen, H. Tamber, H. P. Merkle, and B. Gander. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. Eur. J. Pharm. Biopharm. 47: 193–201 (1999).
A. Sanchéz, B. Villamayor, Y. Guo, J. McIver, and M. J. Alonso. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 185:255–266 (1999).
J. L. Cleland, A. Lim, L. Barrón, E. T. Duenas, and M. F. Powell. Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres. J. Control. Release 47: 135–150 (1997).
T. Uchida, K. Shiosaki, Y. Nakada, K. Fukada, Y. Eda, S. Tokiyoshi, N. Nagareya, and K. Matsuyama. Microencapsulation of hepatitis B core antigen for vaccine preparation. Pharm. Res. 15:1708–1713 (1998).
J. L. Cleland, M. F. Powell, and S. J. Shire. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit. Rev. Ther. Drug Carrier Syst. 10:307–377 (1993).
H. Sah. Protein behavior at the water/methylene chloride interface. J. Pharm. Sci. 88:1320–1325 (1999).
H. Sah. Protein instability toward organic solvent/water emulsification: Implications for protein microencapsulation into microspheres. PDA J. Pharm. Sci. Technol. 53:3–10 (1999).
M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron. Preparation and characterization of protein C-loaded PLA nanoparticles. J. Control. Release 60:179–188 (1999).
M. Morlock, H. Koll, G. Winter, and T. Kissel. Microencapsulation of rh-erythropoietin using biodegradable poly(D,L-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43:29–36 (1997).
M. Iwata, T. Tanaka, Y. Nakamura, and J. W. McGinity. Selection of the solvent system for the preparation of poly(D,L-lactic-co-glycolic acid) microspheres containing tumor necrosis factoralpha (TNF-α). Int. J. Pharm. 160:145–156 (1998).
W. Lu and T. G. Park. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. PDA J. Pharm. Sci. Tech. 49:13–19 (1995).
K. S. Suslick, D. A. Hammerton, and R. E. Cline, Jr. The sonochemical hot spot. J. Am. Chem. Soc. 108:5641–5642 (1986).
P. Reisz and T. Kondo. Free radical formation induced by ultrasound and its biological implications. Free Rad. Biol. Med. 13: 247–270 (1992).
H. Sah. Stabilization of proteins against methylene chloride / water interface-induced denaturation and aggregation. J. Control. Release 58:143–151 (1999).
S. M. Butler, M. A. Tracy, and R. D. Tildon. Adsorption of serum albumin to thin films of poly(lactide-co-glycolide). J. Control. Release 58:335–347 (1999).
M. M. Gaspar, D. Blanco, M. E. M. Cruz, and M. J. Alonso. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, activity and in vitro release. J. Control. Release 52:53–62 (1998).
T. Tsai, R. C. Mehta, and P. P. DeLuca. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 1. Effect of physical factors on the adsorption. Int. J. Pharm. 127:31–42 (1996).
T. Tsai, R. C. Mehta, and P. P. DeLuca. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption. Int. J. Pharm. 127:43–52 (1996).
G. Crotts and T. G. Park. Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles. J. Control. Release 44:123–134 (1997).
K. G. Carrasquillo, R. A. Cordero, S. Ho, J. M. Franquiz, and K. Griebenow. Structure-guided encapsulation of bovine serum albumin in poly(DL-lactic-co-glycolic) acid. Pharm. Pharmacol. Commun. 4:563–571 (1998).
K. Griebenow and A. M. Klibanov. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J. Am. Chem. Soc. 118:11695–11700 (1996).
K. Griebenow and A. M. Klibanov. Can conformational changes be responsible for solvent and excipient effects on the catalytic behavior of subtilisin Carlsberg in organic solvents? Biotechnol. Bioeng. 53:351–362 (1997).
T. Knubovets, J. J. Osterhout, and A. M. Klibanov. Structure of lysozyme dissolved in neat organic solvents as assessed by NMR and CD spectroscopies. Biotechnol. Bioeng. 63:242–248 (1999).
T. G. Park, H. Y. Lee, and Y. S. Nam. A new preparation method for protein loaded poly(D,L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control. Release 55:181–191 (1998).
J.-M. Péan, M.-C. Venier-Julienne, F. Boury, P. Menei, B. Denizot, and J.-P. Benoit. NGF release from poly(D,L-lactide-coglycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. J. Control. Release 56:175–187 (1998).
J.-M. Péan, F. Boury, M.-C. Venier-Julienne, P. Menei, J.-E. Proust, and J.-P. Benoit. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres. Pharm. Res. 16:1294–1299 (1999).
O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones, and S. D. Putney. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 2:795–799 (1996).
B. Bittner, M. Morlock, and H. Koll. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: Influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur. J. Pharm. Biopharm. 45:295–305 (1998).
B. Bittner and T. Kissel. Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. J. Microencapsul. 16:325–341 (1999).
R. Falk, T. W. Randolph, J. D. Meyer, R. M. Kelly, and M. C. Manning. Controlled release of ionic compounds from poly (L-lactide) microspheres produced by precipitation with a compressed antisolvent. J. Control. Release 44:77–85 (1997).
T. J. Young, K. P. Johnston, K. Mishima, and H. Tanaka. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent. J. Pharm. Sci. 88:640–650 (1999).
J. F. Carpenter, M. J. Pikal, B. S. Chang, and T. W. Randolph. Rational design of stable lyophilized protein formulations: Some practical advice. Pharm. Res. 14:969–975 (1997).
M. Morlock, T. Kissel, Y. X. Li, H. Koll, and G. Winter. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: Protein stabilization and in-vitro release properties. J. Control. Release 56:105–115 (1998).
K. G. Carrasquillo, H. R. Costantino, R. A. Cordero, C. C. Hsu, and K. Griebenow. On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. J. Pharm. Sci. 88:166–173 (1999).
K. Fu, K. Griebenow, L. Hsieh, A. M. Klibanov, and R. Langer. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. J. Control. Release 58: 357–366 (1999).
M. van de Weert, R. van 't Hof, J. van der Weerd, R. M. A. Heeren, G. Posthuma, W. E. Hennink, and D. J. A. Crommelin. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR-techniques. J. Control. Release 68:31–40 (2000).
S. Sharif and D. T. O'Hagan. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles. Int. J. Pharm. 115:259–263 (1995).
H. Sah. A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. J. Pharm. Sci. 86:1315–1318 (1997).
M. D. Blanco and M. J. Alonso. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur. J. Pharm. Biopharm. 43:287–294 (1997).
H. Takahata, E. C. Lavelle, A. G. A. Coombes, and S. S. Davis. The distribution of protein associated with poly(DL-lactide-co-glycolide) microparticles and its degradation in simulated body fluids. J. Control. Release 50:237–246 (1998).
H. R. Costantino, R. Langer, and A. M. Klibanov. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J. Pharm. Sci. 83:1662–1669 (1994).
M. C. Lai and E. M. Topp. Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88:489–500 (1999).
A. J. Domb, L. Turovsky, and R. Nudelman. Chemical interactions between drugs containing reactive amines with hydrolyzable insoluble biopolymers in aqueous solutions. Pharm. Res. 11: 865–868 (1994).
S. P. Schwendeman, H. R. Costantino, R. K. Gupta, M. Tobío, A. C. Chang, N. J. Alonso, G. R. Siber, and R. Langer. Strategies for stabilising tetanus toxoid towards the development of a singledose tetanus vaccine. Dev. Biol. Stand. 87:293–306 (1996).
P. G. Shao and L. C. Bailey. Porcine insulin biodegradable polyester microspheres: Stability and in vitro release characteristics. Pharm. Dev. Technol. 5:1–9 (2000).
M. Igartua, R. M. Hernández, A. Esquisabel, A. R. Gascón, M. B. Calvo, and J. L. Pedraz. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. J. Microencapsul. 14:349–356 (1997).
N. Badri Viswanathan, P. A. Thomas, J. K. Pandit, M. G. Kulkarni, and R. A. Mashelkar. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. J. Control. Release 58:9–20 (1999).
W. Wang. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int. J. Pharm. 185:129–188 (1999).
T. G. Park, W. Lu, and G. Crotts. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Release 33:211–222 (1995).
H. K. Sah, R. Toddywala, and Y. W. Chien. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Control. Release 30:201–211 (1994).
M. Igartua, R. M. Hernández, A. Esquisabel, A. R. Gascón, M. B. Calvo, and J. L. Pedraz. Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis. Int. J. Pharm. 169:45–54 (1998).
K. Fu, D. W. Pack, A. Laverdiere, S. Son, and R. Langer. Visualization of pH in degrading polymer microspheres. Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 25:150–151 (1998).
A. Brunner, K. Mäder, and A. Gopferich. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16:847–853 (1999).
P. G. Shao and L. C. Bailey. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. Pharm. Dev. Technol. 4:633–642 (1999).
A. Shenderova, T. G. Burke, and S. P. Schwendeman. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm. Res. 16:241–248 (1999).
K. Mäder, B. Bittner, Y. Li, W. Wohlauf, and T. Kissel. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharm. Res. 15:787–793 (1998).
J. L. Cleland, A. Mac, B. Boyd, J. Yang, C. Hsu, H. Chu, V. Mukku, and A. J. S. Jones. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 14:420–425 (1997).
N. Nihant, C. Schugens, C. Grandfils, R. Jerome, and P. Theyssie. Polylactide microparticles prepared by double emulsionevaporation II. Effect of the poly(lactide-co-glycolide) composition on the stability of the primary and secondary emulsions. J. Colloid Interface Sci. 173:55–65 (1995).
M. S. Hora, R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley, and M. E. Hudson. Release fo human serum albumin from poly-(lactide-co-glycolide) microspheres. Pharm. Res. 7:1190–1194 (1990).
G. Gander, E. Wehrli, R. Alder, and H. Merkle. Quality improvement of spray-dried protein-loaded D, L-PLA microspheres by appropriate polymer solvent selection. J. Microencapsul. 12: 83–97 (1995).
H. K. Lee, J. H. Park, and K. C. Kwon. Double-walled microparticles for single shot vaccine. J. Control. Release 44:283–293 (1997).
N. Wang and X. S. Wu. A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel. Int. J. Pharm. 166:1–14 (1998).
S. P. Schwendeman, M. Tobío, M. Joworowicz, M. J. Alonso, and R. Langer. New strategies for the microencapsulation of tetanus vaccine. J. Microencapsul. 15:299–318 (1998).
M. Tobío, S. P. Schwendeman, Y. Guo, J. McIver, R. Langer, and M. J. Alonso. Improved immunogenicity of a core-coated tetanus toxoid delivery system. Vaccine 18:618–622 (2000).
G. Zhu, S. R. Mallery, and S. P. Schwendeman. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nature Biotechnol. 18:52–57 (2000).
G. Zhu and S. P. Schwendeman. Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices. Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 26:#6446 (1999).
G. Zhu and S. P. Schwendeman. Stabilization of bovine serum albumin encapsulated in injectable poly(lactide-co-glycolide) millicylinders. Proceed. Int'l. Symp. Control. Rel. Bioact. Mater. 25: 267–268 (1998).
C. M. Agrawal and K. A. Athanasiou. Technique to control pH in vicinity of biodegrading PLA-PGA implants. J. Biomed. Mater. Res. 38:105–114 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van de Weert, M., Hennink, W.E. & Jiskoot, W. Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles. Pharm Res 17, 1159–1167 (2000). https://doi.org/10.1023/A:1026498209874
Issue Date:
DOI: https://doi.org/10.1023/A:1026498209874